Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy
利用非病毒 CRISPR/Cas9 基因组编辑技术改造 T 细胞受体融合蛋白，用于癌症免疫治疗
期刊:Bioengineering & Translational Medicine
影响因子:6.1
doi:10.1002/btm2.10571
Runzhe Shu, Maree Hammett, Vera Evtimov, Aleta Pupovac, Nhu-Y Nguyen, Rasa Islam, Junli Zhuang, Seyeong Lee, Tae-Hun Kang, Kyujun Lee, Ian Nisbet, Peter Hudson, Jae Young Lee, Richard Boyd, Alan Trounson
